(redirected from central nervous system)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Continuous net settlement (CNS)

Method of securities clearing and settlement using a clearing house, which matches transactions to securities available, resulting in one net receive or deliver position at the end of the day.

Continuous Net Settlement

A clearing practice in which all buy and sell orders are settled within a brokerage firm. That is, all buy and sell orders are offset against each other on a particular trading day, such that only orders that are "left over" remain to be settled. This results in fewer securities needing to be moved into or out of a particular brokerage.


References in periodicals archive ?
Identify and understand important and diverse types of therapeutics under development for Central Nervous System (CNS) Tumor.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of central nervous system technologies and products.
A snapshot of the global therapeutic scenario for Other Central Nervous System Disorders.
Malan says that immune cells regulate pain sensitivity by releasing substances that make the nerves outside the central nervous system more or less sensitive to pain.
New research report "Central Nervous System Partnering Terms and Agreements" developed by CurrentPartnering is designed to provide an in-depth understanding and unprecedented access to central nervous system partnering deals and agreements entered into by the leading healthcare companies worldwide, besides explaining how and why these companies enter these deals.
Maybe the problem of a lack of growth in the central nervous system is that [damaged] cells don't switch into an actively growing state," suggests Woolf.
This is a mutant rat whose central nervous system is virtually devoid of myelin," he says.
com/reports/c50528) has announced the addition of the new Frost & Sullivan Report "European Central Nervous System (CNS) Therapeutics Markets" to their offering.
It increases the risk of uterine and endometrial cancer, can cause hot flushes, and can disturb the central nervous system, triggering depression, irritability, and short-term memory loss.
The scientists are transplanting the oligos from healthy animals into the central nervous system (CNS) of myelin-deficient ones and witnessing the spread of the myelin-makers, with no evidence of transplant rejection.
Roberts is a world-renowned chemist with more than 30 years of drug development experience at both large pharmaceutical and biotech companies specializing in the treatment of disorders of the central nervous system.
The results overturn a long-accepted theory that central nervous system nerve cells in mammals lose the ability to reproduce before or soon after an individual's birth.

Full browser ?